These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19679174)

  • 1. Targeting retinal and choroid neovascularization using the small molecule inhibitor carboxyamidotriazole.
    Afzal A; Caballero S; Palii SS; Jurczyk S; Pardue M; Geroski D; Edelhauser H; Hochhaus G; Kim M; Franklin A; Shapiro G; Grant MB
    Brain Res Bull; 2010 Feb; 81(2-3):320-6. PubMed ID: 19679174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
    Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
    Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.
    Kusari J; Padillo E; Zhou SX; Bai Y; Wang J; Song Z; Zhu M; Le YZ; Gil DW
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5424-31. PubMed ID: 21482645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
    Seo S; Suh W
    Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization.
    Zeng M; Shen J; Liu Y; Lu LY; Ding K; Fortmann SD; Khan M; Wang J; Hackett SF; Semenza GL; Campochiaro PA
    J Mol Med (Berl); 2017 Apr; 95(4):417-429. PubMed ID: 28004126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization.
    Caballero S; Swaney J; Moreno K; Afzal A; Kielczewski J; Stoller G; Cavalli A; Garland W; Hansen G; Sabbadini R; Grant MB
    Exp Eye Res; 2009 Mar; 88(3):367-77. PubMed ID: 18723015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
    Eyetech Study Group
    Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ocular neovascularization by novel anti-angiogenic compound.
    Gau D; Vignaud L; Francoeur P; Koes D; Guillonneau X; Roy P
    Exp Eye Res; 2021 Dec; 213():108861. PubMed ID: 34822853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.
    Franklin AJ; Jetton TL; Kuchemann CL; Russell SR; Kohn EC
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3756-66. PubMed ID: 15452087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpeptide somatostatin receptor agonists specifically target ocular neovascularization via the somatostatin type 2 receptor.
    Palii SS; Afzal A; Shaw LC; Pan H; Caballero S; Miller RC; Jurczyk S; Reubi JC; Tan Y; Hochhaus G; Edelhauser H; Geroski D; Shapiro G; Grant MB
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5094-102. PubMed ID: 18599562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expression.
    Yang C; Tahiri H; Cai C; Gu M; Gagnon C; Hardy P
    Cardiovasc Ther; 2018 Jun; 36(3):e12329. PubMed ID: 29608244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.
    Hartman GD; Lambert-Cheatham NA; Kelley MR; Corson TW
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization.
    Sheibani N; Wang S; Darjatmoko SR; Fisk DL; Shahi PK; Pattnaik BR; Sorenson CM; Bhowmick R; Volpert OV; Albert DM; Melgar-Asensio I; Henkin J
    Exp Eye Res; 2019 Nov; 188():107798. PubMed ID: 31520600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide, an anti-tumor drug, regulates retinal endothelial cell function: Implication for treating ocular neovascular disorder.
    Dong LF; Yao J; Wang XQ; Shan K; Yang H; Yan B; Jiang Q
    Biochem Biophys Res Commun; 2015 Oct; 465(4):678-84. PubMed ID: 26255966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.
    Nakamura S; Noguchi T; Inoue Y; Sakurai S; Nishinaka A; Hida Y; Masuda T; Nakagami Y; Horai N; Tsusaki H; Hara H; Shimazawa M
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):1943-1952. PubMed ID: 31050722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
    Son Y; Lim D; Park S; Song IS; Kim JH; Shin S; Jang H; Liu KH; O Y; Song GY; Kang W; Cho YS; Na M; Chung H; Oh S
    Pharmacol Res; 2020 Nov; 161():105146. PubMed ID: 32814173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization.
    McAnally D; Siddiquee K; Gomaa A; Szabo A; Vasile S; Maloney PR; Divlianska DB; Peddibhotla S; Morfa CJ; Hershberger P; Falter R; Williamson R; Terry DB; Farjo R; Pinkerton AB; Qi X; Quigley J; Boulton ME; Grant MB; Smith LH
    PLoS One; 2018; 13(9):e0202436. PubMed ID: 30208056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apratoxin S4 Inspired by a Marine Natural Product, a New Treatment Option for Ocular Angiogenic Diseases.
    Qiu B; Tan A; Veluchamy AB; Li Y; Murray H; Cheng W; Liu C; Busoy JM; Chen QY; Sistla S; Hunziker W; Cheung CMG; Wong TY; Hong W; Luesch H; Wang X
    Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):3254-3263. PubMed ID: 31361305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.